| 17beta-estradiol | affects expression | EXP | | 6480464 | Estradiol affects the expression of SYNCRIP mRNA | CTD | PMID:15598610 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SYNCRIP mRNA | CTD | PMID:19465110 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of SYNCRIP mRNA | CTD | PMID:21570461 |
| 2,4-dinitrotoluene | affects expression | ISO | RGD:1305683 | 6480464 | 2,4-dinitrotoluene affects the expression of SYNCRIP mRNA | CTD | PMID:21346803 |
| 2,6-dinitrotoluene | affects expression | ISO | RGD:1305683 | 6480464 | 2,6-dinitrotoluene affects the expression of SYNCRIP mRNA | CTD | PMID:21346803 |
| 2-methylcholine | affects expression | ISO | RGD:1313857 | 6480464 | beta-methylcholine affects the expression of SYNCRIP mRNA | CTD | PMID:21179406 |
| 5-fluorouracil | decreases expression | ISO | RGD:1313857 | 6480464 | Fluorouracil results in decreased expression of SYNCRIP mRNA | CTD | PMID:17039268 |
| arsenite(3-) | affects localization | ISO | RGD:1313857 | 6480464 | arsenite affects the localization of SYNCRIP protein | CTD | PMID:19331829 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1313857 | 6480464 | Benzo(a)pyrene results in decreased expression of SYNCRIP mRNA | CTD | PMID:20106945 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1313857 | 6480464 | Benzo(a)pyrene results in decreased expression of SYNCRIP mRNA | CTD | PMID:20106945 PMID:21632981 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of SYNCRIP mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of SYNCRIP mRNA | CTD | PMID:21715664 |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of SYNCRIP mRNA | CTD | PMID:21932408 |
| bisphenol A | increases expression | ISO | RGD:1313857 | 6480464 | bisphenol A results in increased expression of SYNCRIP mRNA | CTD | PMID:22576693 |
| bisphenol A | decreases methylation | ISO | RGD:1313857 | 6480464 | bisphenol A results in decreased methylation of SYNCRIP gene | CTD | PMID:22576693 |
| choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of SYNCRIP; more ... | CTD | PMID:20938992 |
| cobalt dichloride | decreases expression | ISO | RGD:1313857 | 6480464 | cobaltous chloride results in decreased expression of SYNCRIP mRNA | CTD | PMID:19320972 PMID:19376846 |
| copper atom | multiple interactions | ISO | RGD:1313857 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of SYNCRIP mRNA | CTD | PMID:20971185 |
| copper atom | increases expression | EXP | | 6480464 | Copper results in increased expression of SYNCRIP protein | CTD | PMID:21146535 |
| copper(0) | multiple interactions | ISO | RGD:1313857 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of SYNCRIP mRNA | CTD | PMID:20971185 |
| copper(0) | increases expression | EXP | | 6480464 | Copper results in increased expression of SYNCRIP protein | CTD | PMID:21146535 |
| copper(2+) sulfate | increases expression | ISO | RGD:1313857 | 6480464 | Copper Sulfate results in increased expression of SYNCRIP mRNA | CTD | PMID:19549813 |
| coumestrol | increases expression | ISO | RGD:1313857 | 6480464 | Coumestrol results in increased expression of SYNCRIP mRNA | CTD | PMID:19167446 |
| cyclosporin A | decreases expression | ISO | RGD:1313857 | 6480464 | Cyclosporine results in decreased expression of SYNCRIP mRNA | CTD | PMID:22147139 |
| diarsenic trioxide | increases expression | ISO | RGD:1313857 | 6480464 | arsenic trioxide results in increased expression of SYNCRIP mRNA | CTD | PMID:20458559 |
| elemental selenium | decreases expression | ISO | RGD:1313857 | 6480464 | Selenium results in decreased expression of SYNCRIP mRNA | CTD | PMID:19244175 |
| folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SYNCRIP gene; more ... | CTD | PMID:20938992 |
| hydrogen peroxide | affects expression | ISO | RGD:1313857 | 6480464 | Hydrogen Peroxide affects the expression of SYNCRIP mRNA | CTD | PMID:20044591 |
| kojic acid | increases expression | ISO | RGD:1313857 | 6480464 | kojic acid results in increased expression of SYNCRIP mRNA | CTD | PMID:16595896 |
| L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SYNCRIP mRNA; more ... | CTD | PMID:20938992 |
| paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of SYNCRIP mRNA | CTD | PMID:17562736 |
| paracetamol | decreases expression | ISO | RGD:1313857 | 6480464 | Acetaminophen results in decreased expression of SYNCRIP mRNA | CTD | PMID:21420995 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1313857 | 6480464 | Staurosporine inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of SYNCRIP protein] | CTD | PMID:19331829 |
| phorbol 13-acetate 12-myristate | affects localization | ISO | RGD:1313857 | 6480464 | Tetradecanoylphorbol Acetate affects the localization of SYNCRIP protein | CTD | PMID:19331829 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of SYNCRIP mRNA | CTD | PMID:18445702 |
| piroxicam | increases expression | ISO | RGD:1313857 | 6480464 | Piroxicam results in increased expression of SYNCRIP mRNA | CTD | PMID:21858171 |
| rotenone | increases expression | ISO | RGD:1305683 | 6480464 | Rotenone results in increased expression of SYNCRIP mRNA | CTD | PMID:19013527 |
| selenium atom | decreases expression | ISO | RGD:1313857 | 6480464 | Selenium results in decreased expression of SYNCRIP mRNA | CTD | PMID:19244175 |
| staurosporine | multiple interactions | ISO | RGD:1313857 | 6480464 | Staurosporine inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of SYNCRIP protein] | CTD | PMID:19331829 |
| succimer | multiple interactions | EXP | | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SYNCRIP mRNA | CTD | PMID:21641980 |
| testosterone enanthate | affects expression | ISO | RGD:1313857 | 6480464 | testosterone enanthate affects the expression of SYNCRIP mRNA | CTD | PMID:17440010 |
| thapsigargin | affects localization | ISO | RGD:1313857 | 6480464 | Thapsigargin affects the localization of SYNCRIP protein | CTD | PMID:19331829 |
| trimellitic anhydride | increases expression | EXP | | 6480464 | trimellitic anhydride results in increased expression of SYNCRIP mRNA | CTD | PMID:19042947 |
| valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of SYNCRIP mRNA | CTD | PMID:17292431 |
| valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of SYNCRIP mRNA | CTD | PMID:21427059 |
| valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of SYNCRIP mRNA | CTD | PMID:21427059 PMID:19136453 |
| valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of SYNCRIP mRNA | CTD | PMID:19136453 PMID:21427059 |